STC heads into earnings with analysts cautious and options turning bullish

STC reports Q3 results tomorrow, October 22, with the stock down 17% over the past month and trading at $52.42, a price that sits roughly 33% below the Street's mean target of $79. That gap is the central tension heading into the print: analysts still see material upside, but the market has been pricing something closer to a structural reset.

The options market is not expressing much fear right now, which is worth noting given the recent selloff. The put/call ratio has pulled back sharply to 0.47, well below its 20-day average of 1.18 and sitting near the lower end of the past year's range. This is a notable reversal from late September, when the ratio briefly touched 3.0, signalling heavy demand for downside protection. That hedging has since unwound. The borrow market reinforces the picture of limited short-side aggression: short interest has fallen 17% over the past month to 3.8% of free float, and availability is extremely loose at roughly 3,959%, meaning shares to borrow vastly outnumber those already borrowed. Borrowing cost is negligible at under 0.47% annualised. There is no meaningful squeeze dynamic here, and the short-side is not pressing a strong view.

The analyst community is constructive but trimming. Most firms still carry buy-equivalent ratings, with Benchmark initiating at Buy and a $87 target in July, and Stephens holding at Overweight with an $88 target. The most recent move came from Citizens on October 12, where Matthew Carletti cut his target from $80 to $75 while keeping a Market Outperform rating. Keefe, Bruyette & Woods downgraded to Market Perform back in July after cutting its target to $71, citing margin risks and tougher year-over-year comparisons in commercial real estate revenues. The bear case centres on operating margin pressure: segment margins have been revised down to 11% for 2025, and management flagged that the 46% year-over-year commercial revenue growth seen in Q2 would face harder comparisons in the second half. The bull case leans on a medium-term earnings ramp, with segment earnings projected to rise from around $46 million to $72 million by 2027. On valuation, the stock trades at just 8.9 times trailing earnings and 0.9 times book, both at the lower end of recent history given a 30-day compression in price-to-book of roughly 16%.

Wikipedia traffic for STC was running at a z-score of 3.3 relative to its own 90-day history as of late September, indicating a spike in retail attention well above normal levels. This is an attention signal rather than a fundamental indicator, but it does align with the period of sharp price weakness and elevated put/call readings, suggesting retail investors were paying close attention to the selloff. No alt-data dataset for STC has been measured to lead its reported figures, so this cannot be read as a directional signal for the earnings print.

The closest peer, FAF, gained 6.6% on the week and FNF added 3.2%, while STC managed a more modest 2.9% recovery. The title insurance group broadly rallied, but STC has underperformed consistently. The previous earnings reaction is worth noting: following the July 23 print, the stock fell 3.3% the next day and continued lower over the following week. The Q3 report drops at 12:30 UTC tomorrow, and the key question is whether commercial revenue growth and margin recovery are tracking the more conservative post-downgrade forecasts, or whether the month's selloff has already priced in something worse than the bear case.